Visby Medical has announced partnerships with Quest Diagnostics and Labcorp to expand distribution of its at-home PCR test for sexually transmitted infections. The Visby Women’s Sexual Health Test is the first FDA-authorized at-home PCR test for STIs available to consumers.
The palm-sized device delivers results for chlamydia, gonorrhea, and trichomoniasis in 30 minutes. Users collect a vaginal swab, insert it into the device, and receive results through Visby’s app. Unlike most at-home STI kits, the test does not require mailing samples to a lab.
The test is now available on questhealth.com and Labcorp OnDemand. Ovia Health, Labcorp’s women’s health app, plans to offer the test to its employer and health plan partners in early 2026.
Nearly 100,000 women in the U.S. lose their fertility each year due to complications from untreated STIs, according to the company. Many infections present without symptoms while causing damage to the reproductive system.
“Infectious disease management relies heavily on the speed of diagnosis, and for too long, women’s health has been hindered by delays,” said Gary Schoolnik, MD, Chief Medical Officer of Visby Medical. “When a patient has to wait days for a result, we risk the infection spreading or developing into Pelvic Inflammatory Disease (PID). The expansion of this test provides immediate, lab-quality accuracy at home, which can move patients from diagnosis to treatment in a single day, preserving their long-term health.”
Dr. Leslie Saltzman, Medical Discipline Director of Consumer Health at Labcorp, said: “For many patients, privacy and convenience are essential to seeking care. As a physician, I see firsthand how a timely and accurate diagnosis is critical to preventing complications from STIs. Collaborating with Visby allows us to offer a fully at-home option that combines accuracy, privacy, and convenience.”
Mark Kruzel, MD, Medical Director of Consumer for Quest Diagnostics, added: “Expanding access to timely STI testing is a critical part of improving women’s health. The addition of the Visby test to the questhealth.com menu will give women greater options for illuminating a path to good health, supplementing our comprehensive STI offerings.”
